Your activity: 120 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Calculator: VTE-BLEED score for risk of bleeding among adults receiving long-term anticoagulation


Calculator: VTE-BLEED score for risk of bleeding among adults receiving long-term anticoagulation

 
Input
 

Active cancer? (2)

Male with uncontrolled hypertension? (1)

Anemia? (1.5)

History of bleeding? (1.5)

Kidney dysfunction? [creatinine clearance 30 to 60 mL/min]* (1.5)

Age 60 years or older? (1.5)

 
Result
 
 
Risk score  
 

 

 

Risk of major bleeding in the first 6 months following initial 30 days of stable anticoagulation with warfarin or initiation of dabigatran

 
VTE-BLEED risk score points Bleeding risk category Incidence of major bleeding
<2 Low risk 2.8%
≥2 Elevated risk 12.6%

 
 

 
Notes
  • *Anticoagulation with dabigatran is contraindicated for patients with estimated creatinine clearance of less than 30 mL/min.
  • This bleeding risk estimation tool was generated from data in patients taking warfarin (target range INR 2 to 3) or the direct thrombin inhibitor dabigatran (ie, a DOAC). The incidence of bleeding with warfarin may be higher than that associated with DOACs, which also include factor Xa inhibitors (eg, rivaroxaban, apixaban).
  • VTE: venous thromboembolism; INR: international normalized ratio; DOAC: direct oral anticoagulant.

 
Only digits 0 to 9 and a single decimal point (".") are acceptable as numeric inputs. Attempted input of other characters into a numeric field may lead to an incorrect result.

Information on this page may not appear correctly if printed.

Legal Notices and Disclaimer

All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer.

EBMcalc is Copyright © 1998-2023 Foundation Internet Services, LLC

Topic 131287 Version 3.0